391 drugs were shortlisted or procured in volume.

Pharmaceutical Network September 25th, 391 drugs into the shortlist, or was taken to purchase 391 drugs into the volume of procurement candidates according to WeChat public number "Pharmaceutical Representative" news, yesterday (September 23) morning, The Office of the Procurement Working Group of Guangxi Pharmaceutical Group held a consultation meeting on the work programme of centralized procurement and use of high-value medical supplies organized by the state organization and the procurement (second batch) of Guangxi Pharmaceutical Group, at which the participants were consulted on the second batch of Guangxi Pharmaceutical Group procurement work programme.
circulating documents show that Guangxi second batch of pharmaceutical group procurement will be purchased varieties from the state to provide the first screening varieties, Guangxi this list of candidate varieties includes 391 drugs, many of which have a proportion of injection type.
documents show that before September 30, Guangxi will officially announce the Guangxi Pharmaceutical Group procurement (second batch) varieties catalog, before October 31, Guangxi will organize the bidding work, before November 30, Guangxi will determine and announce the results of the election, Before December 31, Guangxi will officially carry out the procurement of selected varieties.
, with only the last few days left, which of these 391 varieties will be included in the second batch of group procurement in Guangxi, will be officially announced.
list of 500 varieties is a reference range it is worth noting that the circulating documents show that Guangxi this time the candidate list is from the country to provide the first screening varieties of choice.
the list of 500 species that had been circulating, it did match a large number of varieties.
according to industry news, at the end of July this year held a national collection-related meeting, out of several information: 1, according to the purchase amount of sorting, covering the first 80% of the varieties, selected 500 varieties.
is expected to have 250 in 2021 and 500 varieties of strip procurement by 2022;
areas that have not been carried out need to act quickly, and areas not carried out at the national level are organized by the provinces;
countries do not carry out with-volume procurement of varieties, by the provincial organizations to carry out.
In addition, at the recent "China Pharmaceutical Enterprise Management Association 8th Second President (Expansion) Conference and the 37th China Medical Industry Summit Forum" hosted by Saibai Blue, Physicians Services, Saibai Blue confirmed from the authorities, Guangdong will soon start 500 varieties of belt procurement work, is still studying the details.
because the list of 500 varieties included in the industry is considered unlikely to be collected varieties, such as exclusive varieties, single resistance, so the list of authenticity, the industry has been different views.
But from another point of view, a total of 113 varieties from the three batches so far are on the list of 500 varieties, which to some extent also validates that this reference list may be valid if only from the point of view of the purchase amount.
can not be ignored is that, with the local collection news out, 500 varieties list of practical is gradually confirmed, whether there will be more provinces and cities to follow up, may be the industry's more concern.
Guangxi collection range: base drugs and medical insurance varieties according to Saibai Blue query, Guangxi Pharmaceutical Group procurement service platform since August 2019 began to follow up the release of the relevant documents of the national organization of drug collection, and responsible for the national organization of drug collection in Guangxi related work.
as early as August 9 last year, Guangxi issued the "Autonomous Region Pharmaceutical Group Procurement Working Group Office on the implementation of drug group procurement in the region notice" began to explore local volume procurement.
according to the notice, Guangxi's drug collection documents mainly refer to the "Guidance of the General Office of the State Council on improving the centralized procurement of medicines in public hospitals" (State Office issued (2015) No. 7) and "Several opinions of the General Office of the State Council on further reform and improvement of the policy on the production and circulation of drugs" (State Office issued No. 13 of 2017).
According to the comparison of Cypress Blue combing, Guangxi's local collection, although called group procurement, but in some specific rules or obviously with the national organization of drug collection shadow - such as the prior provision of procurement volume to ensure the volume of procurement, as well as the volume of price linkage, volume exchange, guarantee the use of the principle of implementation.
The notice of procurement of Guangxi Pharmaceutical Group stipulates that the procurement varieties of pharmaceutical groups shall be selected by the Office from the current National Basic Drug Catalog, the National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog, and the generic drugs corresponding to the scope of basic medical insurance in Guangxi, and shall be determined by the Office after consultation with experts and consultation with representatives of medical and health institutions, and published in batches in the form of the procurement catalogue.
Narcotic drugs, psychotic drugs, toxic drugs for medical use, radioactive drugs, free medicines for the prevention and treatment of infectious and parasitic diseases, national immunization programme vaccines and family planning drugs are not included in the scope of procurement by Guangxi Pharmaceutical Group.
local characteristics, can be negotiated according to the Cypress Blue inquiry, as early as August 23, 2019, Guangxi Pharmaceutical Group procurement service platform issued the "Guangxi Pharmaceutical Group Procurement (first batch) announcement."
the first batch of pharmaceutical group procurement in Guangxi involved a total of 32 varieties of 86 specifications, a total of 15 integrated areas of the region's procurement volume, procurement cycle is also one year.
After the first batch of pharmaceutical group procurement, in July this year, Guangxi also issued the "Autonomous Region Drug Group Procurement Working Group Office on the purchase of drugs group of the autonomous region on the request for the autonomous region drug group procurement (second batch) related to the work of the announcement", publicly on the number of selected enterprises, quality hierarchy, the second batch of pharmaceutical group procurement catalog selection principles, shortlisted prices, the national minimum price determination and other issues to solicit views.
Different from the national organization of drug collection, Guangxi in addition to production enterprises and distribution enterprises have a lot of qualification requirements on the refinement, for the procurement of varieties of levels and dosage forms also have specific subdivision, on the choice of distribution enterprises Guangxi has also drawn up a set of scoring standards.
In addition, Guangxi's notice stipulates that the drugs included in the Group's procurement catalogue shall be determined by different means the selected varieties and the Group's purchase price: (1) bidding: the number of products in the same group of valid registration is 3, and the price is generally determined through bidding.
(ii) bargaining negotiations: the number of valid registration of the same group of products is less than 2, through bargaining negotiations to determine the price.
the specifics of the work are determined by the Office in accordance with the procurement needs of the Pharmaceutical Group.
specifically, if the selected varieties and purchase prices are determined by means of bargaining negotiations, the expert group shall conduct negotiations on bargaining.
expert group members are drawn from the pool of pharmaceutical group procurement experts.
Pharmaceutical Group procurement expert pool experts by the Office to select relevant pharmaceutical experts, medical experts, medical insurance experts, pharmaceutical economics experts and domestic drug procurement industry experts, management measures to be formulated separately.
of The Guangxi Notice stipulates that the total amount of procurement by the Group shall be determined according to 60% of the amount committed to procurement by medical and health institutions.
health-care institutions involved in the procurement of pharmaceutical groups are required to ensure that the procurement and use of selected medicines is completed in one procurement cycle in accordance with the committed quantities of medicines procured.
as for distribution, the production enterprises of the selected drugs shall select more than 3 or more drug distribution enterprises within 6 through the Guangxi Pharmaceutical Group procurement service platform, and the final distribution enterprises shall be determined by the medical and health institutions.
enterprises to carry out their own drug distribution services.
this and the national organization of drug collection for the number of distribution enterprises are not the same.
because the local collections in different regions have their own innovation and differences, enterprises still need to maintain a moderate degree of attention.
based on local harvesting, another issue of greatest concern is undoubtedly whether more provinces will follow suit in the procurement of medicines from the 500-variety list.
attached: 391 variety catalogues.